Sunshine Biopharma Share Price (NASDAQ: SBFM)

$1.39

▲

-0.01

(-0.71%)

Live

Last updated on August 27, 2025 at 1:29 AM IST

$₹

Check the interactive Sunshine Biopharma Stock chart to analyse performance

Sunshine Biopharma stock performance

as on August 27, 2025 at 1:29 AM IST

Today's Low:$1.37
Today's High:$1.39
$1.39
1.44%
Downside
Day's Volatility :1.44%
Upside
0.0%
52 Weeks Low:$1.17
52 Weeks High:$3.90
$1.39
15.88%
Downside
52 Weeks Volatility :70.02%
Upside
64.36%

Sunshine Biopharma Stock Returns

Period	Sunshine Biopharma Inc	Index (Russel 2000)
3 Months	-1.4%	0.0%
6 Months	-39.74%	0.0%
1 Year	-51.88%	0.0%
3 Years	-99.94%	-6.9%

Sunshine Biopharma Inc Key Stats

Check Sunshine Biopharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$1.4
Open	$1.37
Today's High	$1.46
Today's Low	$1.37
Market Capitalization	$6.4M
Today's Volume	$94.8K
52 Week High	$3.9
52 Week Low	$1.1693
Revenue TTM	$36.3M
EBITDA	$-5.2M
Earnings Per Share (EPS)	$-15.02
Profit Margin	-17.35%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-25.65%

Stock Returns calculator for Sunshine Biopharma Stock including INR - Dollar returns

The Sunshine Biopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sunshine Biopharma investment value today

Current value as on today

₹51,952

Returns

₹48,048

(-48.05%)

Returns from Sunshine Biopharma Stock

₹52,560 (-52.56%)

Dollar Returns*

₹4,511 (+4.51%)

Indian investors sentiment towards Sunshine Biopharma Stock

-13%

Period: Jul 26, 2025 to Aug 25, 2025. Change in 30 Days versus previous period

Search interest for Sunshine Biopharma Stock from India on INDmoney has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sunshine Biopharma Inc

Name
Holdings %
Name
Holdings %
Altium Capital Management, LP
1.11%
UBS Group AG
0.44%
SBI Securities Co Ltd
0.11%
Morgan Stanley - Brokerage Accounts
0.08%

Analyst Recommendation on Sunshine Biopharma Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Sunshine Biopharma(by analysts ranked 0 to 5 stars)

Sunshine Biopharma Share Price Target

What analysts predicted

Upside of 403.6%

Target:

$7.00

Current:

$1.39

Sunshine Biopharma share price target is $7.00, a slight Upside of 403.6% compared to current price of $1.39 as per analysts' prediction.

Sunshine Biopharma Stock Insights

Price Movement
In the last 3 years, SBFM stock has moved down by -99.9%
Increasing Revenue
Revenue is up for the last 2 quarters, 8.90M → 9.41M (in $), with an average increase of 5.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.18M → -1.77M (in $), with an average decrease of 50.1% per quarter
SBFM vs HLN (1 yr)
In the last 1 year, Sunshine Biopharma Inc has experienced a drawdown of -51.9%, however Haleon Plc Spon Ads resisted the overall trend and outperformed by 49.9%
SBFM vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 55.2% return, outperforming this stock by 155.1%
Price to Sales
ForSBFM every $1 of sales, investors are willing to pay $0.1, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Sunshine Biopharma Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$21.1K	↓ 95.28%
Net Income	$-1.7M	↓ 22.99%
Net Profit Margin	-7.9K%	↓ 7378.74%

	FY20	Y/Y Change
Revenue	$71.4K	↑ 238.1%
Net Income	$-2.8M	↑ 67.69%
Net Profit Margin	-3.9K%	↑ 3962.11%

	FY21	Y/Y Change
Revenue	$228.4K	↑ 219.88%
Net Income	$-12.4M	↑ 346.68%
Net Profit Margin	-5.4K%	↓ 1545.47%

	FY22	Y/Y Change
Revenue	$4.3M	↑ 1802.59%
Net Income	$-26.7M	↑ 115.05%
Net Profit Margin	-615.37%	↑ 4828.84%

	FY23	Y/Y Change
Revenue	$24.1M	↑ 454.37%
Net Income	$-4.5M	↓ 83.15%
Net Profit Margin	-18.7%	↑ 596.67%

	FY24	Y/Y Change
Revenue	$34.9M	↑ 44.75%
Net Income	$-5.1M	↑ 13.94%
Net Profit Margin	-14.72%	↑ 3.98%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$7.5M	↓ 1.81%
Net Income	$-1.3M	↑ 2.72%
Net Profit Margin	-17.03%	↓ 0.75%

	Q2 FY24	Q/Q Change
Revenue	$9.3M	↑ 23.37%
Net Income	$-494.0K	↓ 61.53%
Net Profit Margin	-5.31%	↑ 11.72%

	Q3 FY24	Q/Q Change
Revenue	$8.4M	↓ 9.33%
Net Income	$-1.2M	↑ 142.51%
Net Profit Margin	-14.2%	↓ 8.89%

	Q4 FY24	Q/Q Change
Revenue	$9.6M	↑ 13.75%
Net Income	$-2.2M	↑ 80.15%
Net Profit Margin	-22.49%	↓ 8.29%

	Q1 FY25	Q/Q Change
Revenue	$8.9M	↓ 7.23%
Net Income	$-1.2M	↓ 45.33%
Net Profit Margin	-13.26%	↑ 9.23%

	Q2 FY25	Q/Q Change
Revenue	$9.4M	↑ 5.72%
Net Income	$-1.8M	↑ 50.07%
Net Profit Margin	-18.82%	↓ 5.56%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$10.1K	↓ 82.05%

	FY20	Y/Y Change
Profit	$45.6K	↑ 352.42%

	FY21	Y/Y Change
Profit	$110.6K	↑ 142.73%

	FY22	Y/Y Change
Profit	$1.7M	↑ 1434.41%

	FY23	Y/Y Change
Profit	$8.3M	↑ 391.4%

	FY24	Y/Y Change
Profit	$10.7M	↑ 27.95%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$2.3M	↓ 9.97%

	Q2 FY24	Q/Q Change
Profit	$2.3M	↓ 0.3%

	Q3 FY24	Q/Q Change
Profit	$2.9M	↑ 24.34%

	Q4 FY24	Q/Q Change
Profit	$3.1M	↑ 7.92%

	Q1 FY25	Q/Q Change
Profit	$2.7M	↓ 11.74%

	Q2 FY25	Q/Q Change
Profit	$3.4M	↑ 25.38%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-495.8K	↓ 3.32%
Investing Cash Flow	$-15.3K	↑ 9.84%
Financing Cash Flow	$442.3K	↓ 16.18%

	FY20	Y/Y Change
Operating Cash Flow	$-657.3K	↑ 32.57%
Investing Cash Flow	$-1.2K	↓ 92.2%
Financing Cash Flow	$1.6M	↑ 263.65%

	FY21	Y/Y Change
Operating Cash Flow	$-1.8M	↑ 178.28%
Investing Cash Flow	$-14.6M	↑ 1227388.66%
Financing Cash Flow	$2.9M	↑ 80.61%

	FY22	Y/Y Change
Operating Cash Flow	$-5.2M	↑ 186.93%
Investing Cash Flow	$-14.6M	↑ 0.0%
Financing Cash Flow	$39.5M	↑ 1258.68%

	FY23	Y/Y Change
Operating Cash Flow	$-8.8M	↑ 67.2%
Investing Cash Flow	$-656.2K	↓ 95.51%
Financing Cash Flow	$3.4M	↓ 91.32%

	FY24	Y/Y Change
Operating Cash Flow	$-12.5M	↑ 42.8%
Investing Cash Flow	$-2.3M	↑ 253.71%
Financing Cash Flow	$9.3M	↑ 171.18%

Q1 FY24

Q2 FY24

Q3 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-3.2M	↑ 18.42%
Investing Cash Flow	$-668.7K	↑ 148.39%
Financing Cash Flow	$5.4M	↓ 17787.83%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.6M	↑ 43.72%
Investing Cash Flow	$-542.2K	↓ 18.92%
Financing Cash Flow	$-28.6K	↓ 100.53%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-1.4M	↓ 70.27%
Investing Cash Flow	$-578.4K	↑ 6.67%
Financing Cash Flow	$1.9M	↓ 6628.19%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-1.7M	↓ 49.7%
Investing Cash Flow	$-176.0K	-
Financing Cash Flow	$338.1K	↓ 83.54%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-1.3M	↓ 25.7%
Investing Cash Flow	$-491.8K	↑ 179.38%
Financing Cash Flow	$3.6M	↑ 967.68%

Sunshine Biopharma Technicals Summary

Sell

Neutral

Buy

Sunshine Biopharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sunshine Biopharma Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sunshine Biopharma Inc	-7.24%	-39.74%	-51.88%	-99.94%	-99.99%
Haleon Plc Spon Ads	-0.31%	-4.73%	-2.03%	59.31%	30.5%
United Therapeutics Corporation	2.4%	-14.6%	-11.93%	40.37%	71.69%
Zoetis Inc.	2.91%	-7.95%	-14.56%	-1.74%	-2.81%
Neurocrine Biosciences Inc.	0.24%	15.65%	-11.98%	27.26%	17.4%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sunshine Biopharma Inc	0.0	NA	0.0	-0.57	-0.26	-0.11	NA	5.64
Haleon Plc Spon Ads	21.82	21.82	3.16	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.91	11.91	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.71	26.71	2.54	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	39.53	39.53	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sunshine Biopharma Inc	Buy	$6.4M	-99.99%	0.0	-17.35%
Haleon Plc Spon Ads	Buy	$44.2B	30.5%	21.82	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.69%	11.91	40.36%
Zoetis Inc.	Buy	$68.8B	-2.81%	26.71	27.83%
Neurocrine Biosciences Inc.	Buy	$13.3B	17.4%	39.53	13.88%

About Sunshine Biopharma Inc

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Organization	Sunshine Biopharma
Employees	52
CEO	Dr. Steve N. Slilaty Ph.D.
Industry	Pharmaceuticals: Other

Key Management of Sunshine Biopharma Inc

Name	Title
Dr. Steve N. Slilaty Ph.D.	Chairman, President & CEO
Mr. Camille Sebaaly	CFO & Secretary
Dr. Abderrazzak Merzouki	COO & Director
Mr. Malek Chamoun	Chief Development Officer
Mr. Michel Roy	Chief Commercial Officer
Mr. Robert G. Ferreira	President of Sunshine Bio Investments Inc

Important FAQs about investing in SBFM Stock from India :

What is Sunshine Biopharma share price today?

Sunshine Biopharma share price today is $1.39 as on August 27, 2025 at 1:29 AM IST. Sunshine Biopharma share today touched a day high of $1.39 and a low of $1.37.

What is the 52 week high and 52 week low for Sunshine Biopharma share?

Sunshine Biopharma share touched a 52 week high of $3.90 and a 52 week low of $1.17. Sunshine Biopharma stock price today i.e. August 27, 2025 at 1:29 AM IST is trending at $1.39, lower by 64.36% versus the 52 week high.

How to invest in Sunshine Biopharma Stock (SBFM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sunshine Biopharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sunshine Biopharma Shares that will get you 1.0791 shares as per Sunshine Biopharma share price of $1.39 per share as on August 27, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Sunshine Biopharma Stock (SBFM) from India?

Indian investors can start investing in Sunshine Biopharma (SBFM) shares with as little as ₹87.639 or $1 (as of August 26, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.39 in Sunshine Biopharma stock (as per the Rupee-Dollar exchange rate as on August 26, 2025). Based on Sunshine Biopharma share’s latest price of $1.39 as on August 27, 2025 at 1:29 AM IST, you will get 7.1942 shares of Sunshine Biopharma. Learn more about fractional shares .

What are the returns that Sunshine Biopharma has given to Indian investors in the last 5 years?

Sunshine Biopharma stock has given -99.99% share price returns and 18.59% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?